Zwijnaarde
Belgium
215
2026-05-21
144
2025-02-11
These are the the leading inventors for applications assigned to Ablynx N.V.:
Ablynx N.V. based in Zwijnaarde, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
IMMUNOGLOBULIN VARIABLE DOMAINS
#2 | 2026-05-21PRECISION ACTIVATED POLYPEPTIDES
#3 | 2026-02-12CHROMATOGRAPHY-FREE ANTIBODY PURIFICATION METHOD
#4 | 2025-07-24PROTEIN-BASED CARRIERS FOR SITE-SPECIFIC AMINE CONJUGATION
#5 | 2025-04-24MMP13 BINDING IMMUNOGLOBULINS
#6 | 2025-04-17METHOD FOR THE PRODUCTION OF DOMAIN ANTIBODIES
#7 | 2024-12-19PROTEIN-BASED CONJUGATION CARRIERS
#8 | 2024-11-07POLYPEPTIDES BINDING TO THE NEONATAL FC RECEPTOR
#9 | 2024-10-17POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING GLYPICAN-3 AND T CELL RECEPTOR
#10 | 2024-09-12POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING IL-6 AND TNF ALPHA
#11 | 2024-09-05SERUM ALBUMIN BINDERS
#12 | 2024-08-22 β Patent 12,221,487 granted on 2025-02-11CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#13 | 2024-06-20T CELL RECRUITING POLYPEPTIDES CAPABLE OF BINDING CD123 AND TCR ALPHA/BETA
#14 | 2024-06-06AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM
#15 | 2024-06-06POLYPEPTIDES BINDING ADAMTS5, MMP13 AND AGGRECAN
#16 | 2024-04-11CX3CR1-BINDING COMPOUNDS, METHODS AND USES THEREOF
#17 | 2024-04-04IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING T CELL RECEPTOR
#18 | 2024-01-25CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#19 | 2023-10-05AGGRECAN BINDING IMMUNOGLOBULINS
#20 | 2023-08-03TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#21 | 2023-07-06 β Patent 12,384,835 granted on 2025-08-12CYSTEINE LINKED NANOBODY DIMERS
#22 | 2023-05-04METHOD FOR THE PRODUCTION AND PURIFICATION OF MULTIVALENT IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#23 | 2023-03-02 β Patent 12,630,617 granted on 2026-05-19SERUM ALBUMIN BINDERS
#24 | 2023-02-16 β Patent 12,662,527 granted on 2026-06-23IMPROVED SERUM ALBUMIN BINDING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#25 | 2023-02-16 β Patent 12,221,487 granted on 2025-02-11Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
#26 | 2023-02-02NANOBODIES AGAINST TUMOR NECROSIS FACTOR-ALPHA
#27 | 2022-12-29 β Patent 11,919,966 granted on 2024-03-05Methods for inhibiting tumor growth or treating cancer by administering an immunoglobulin single variable domain that binds glucocorticoid-induced TNFR family-related receptor (GITR)
#28 | 2022-11-24POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFA AND IL-23
#29 | 2022-11-17 β Patent 12,528,860 granted on 2026-01-20POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFA AND IL-23
#30 | 2022-11-17 β Patent 12,285,493 granted on 2025-04-29Polypeptides antagonizing Wnt signaling in tumor cells
#31 | 2022-11-10 β Patent 11,897,951 granted on 2024-02-13Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-Ξ±
#32 | 2022-10-20IMMUNOGLOBULIN VARIABLE DOMAINS
#33 | 2022-10-20IMMUNOGLOBULIN VARIABLE DOMAINS
#34 | 2022-10-13GLYCOSYLATED IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#35 | 2022-09-22 β Patent 12,662,525 granted on 2026-06-23TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#36 | 2022-08-11 β Patent 11,708,404 granted on 2023-07-25Immunoglobulin variable domains
#37 | 2022-08-04BISPECIFIC NANOBODIES
#38 | 2022-07-07 β Patent 11,932,702 granted on 2024-03-19Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptor
#39 | 2022-06-09 β Patent 12,492,248 granted on 2025-12-09POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING IL-13 AND TSLP
#40 | 2022-06-09 β Patent 11,840,566 granted on 2023-12-12Methods of treating asthma with polypeptides targeting IL-13 and TSLP
#41 | 2022-06-09 β Patent 12,384,840 granted on 2025-08-12POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING IL-13 AND TSLP
#42 | 2022-06-09FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
#43 | 2022-05-19 β Patent 12,509,522 granted on 2025-12-30POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING IL-13 AND OX40L
#44 | 2022-05-05 β Patent 11,312,765 granted on 2022-04-26Immunoglobulin variable domains
#45 | 2022-04-21 β Patent 11,485,778 granted on 2022-11-01Immunoglobulin variable domains
#46 | 2022-04-21 β Patent 12,516,105 granted on 2026-01-06TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#47 | 2022-03-03 β Patent 11,332,525 granted on 2022-05-17Polypeptides comprising immunoglobulin single variable domains targeting TNFA and IL-23
#48 | 2021-12-30TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#49 | 2021-12-16TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#50 | 2021-12-16TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#51 | 2021-12-02 β Patent 12,479,885 granted on 2025-11-25CHROMATOGRAPHY-FREE ANTIBODY PURIFICATION METHOD
#52 | 2021-09-02 β Patent 11,319,364 granted on 2022-05-03Immunoglobulin variable domains
#53 | 2021-09-02 β Patent 11,312,765 granted on 2022-04-26Immunoglobulin variable domains
#54 | 2021-08-26 β Patent 11,485,777 granted on 2022-11-01Immunoglobulin variable domains
#55 | 2021-07-15 β Patent 11,208,476 granted on 2021-12-28Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP
#56 | 2021-06-24 β Patent 11,753,465 granted on 2023-09-12Nucleic acids encoding polypeptides against IL-23
#57 | 2021-06-24POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING IL-13 AND TSLP
#58 | 2021-06-24POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFA AND IL-23
#59 | 2021-05-13 β Patent 11,858,997 granted on 2024-01-02Amino acid sequences that modulate the interaction between cells of the immune system
#60 | 2021-04-22 β Patent 11,603,401 granted on 2023-03-14Aggrecan binding immunoglobulins
#61 | 2021-03-25 β Patent 11,220,539 granted on 2022-01-11Immunoglobulin variable domains
#62 | 2021-02-18 β Patent 11,851,480 granted on 2023-12-26Method for the production of immunoglobulin single variable domains
#63 | 2021-01-14 β Patent 11,813,307 granted on 2023-11-14Polypeptides binding ADAMTS5, MMP13 and aggrecan
#64 | 2020-10-08 β Patent 11,261,260 granted on 2022-03-01ADAMTS binding immunoglobulins
#65 | 2020-09-10 β Patent 11,332,519 granted on 2022-05-17Serum albumin binders
#66 | 2020-06-18 β Patent 12,129,308 granted on 2024-10-29MMP13 binding immunoglobulins
#67 | 2020-05-21 β Patent 11,840,569 granted on 2023-12-12T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
#68 | 2020-05-07AGGRECAN BINDING IMMUNOGLOBULINS
#69 | 2020-04-23 β Patent 11,518,799 granted on 2022-12-06Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
#70 | 2020-03-12 β Patent 11,472,871 granted on 2022-10-18Nanobodies against tumor necrosis factor-alpha
#71 | 2019-12-05 β Patent 11,897,944 granted on 2024-02-13Immunoglobulin single variable domain (ISVD) capable of binding to serum albumin
#72 | 2019-12-05 β Patent 11,414,481 granted on 2022-08-16Serum albumin binders
#73 | 2019-12-05 β Patent 11,414,480 granted on 2022-08-16Serum albumin binding immunoglobulin single variable domains
#74 | 2019-10-24 β Patent 11,384,151 granted on 2022-07-12CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
#75 | 2019-05-16 β Patent 11,370,835 granted on 2022-06-28Methods for purification of single domain antigen binding molecules
#76 | 2019-04-25 β Patent 11,149,089 granted on 2021-10-19Method for treating rheumatoid arthritis by administering IL-6 receptor antibodies
#77 | 2019-02-21 β Patent 11,312,788 granted on 2022-04-26PcrV binding single variable domain antibodies
#78 | 2019-01-24 β Patent 10,808,032 granted on 2020-10-20Biological materials related to HER3
#79 | 2019-01-10 β Patent 12,662,550 granted on 2026-06-23STABLE FORMULATIONS OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#80 | 2018-12-13 β Patent 11,248,055 granted on 2022-02-15Polypeptides inhibiting CD40L
#81 | 2018-11-01 β Patent 11,142,569 granted on 2021-10-12Serum albumin-binding immunoglobulin variable domains
#82 | 2018-01-25 β Patent 11,466,089 granted on 2022-10-11Chemokine receptor binding polypeptides
#83 | 2018-01-18 β Patent 10,618,966 granted on 2020-04-14Methods for the treatment of interleukin-6 receptor-related diseases and disorders
#84 | 2018-01-11TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#85 | 2017-11-23 β Patent 10,100,110 granted on 2018-10-16Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the treatment of cancers and/or tumors
#86 | 2017-11-23 β Patent 11,007,146 granted on 2021-05-18Methods and compositions for the preparation of aerosols
#87 | 2017-09-28 β Patent 11,192,938 granted on 2021-12-07Serum albumin binding proteins containing immunoglobulin single variable domains
#88 | 2017-09-28 β Patent 11,192,937 granted on 2021-12-07Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
#89 | 2017-09-21 β Patent 10,544,211 granted on 2020-01-28TNF binders
#90 | 2017-09-07INHIBITION OF BONE RESORPTION WITH RANKL BINDING PEPTIDES
#91 | 2017-07-27 β Patent 10,858,445 granted on 2020-12-08Methods of treating TTP with immunoglobulin single variable domains and uses thereof
#92 | 2017-07-27SERUM ALBUMIN BINDING PROTEINS
#93 | 2017-07-06 β Patent 9,745,372 granted on 2017-08-29TNF binders
#94 | 2017-06-15 β Patent 11,078,290 granted on 2021-08-03Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#95 | 2017-05-18 β Patent 11,149,086 granted on 2021-10-19KV1.3 binding immunoglobulins
#96 | 2017-05-04 β Patent 12,180,268 granted on 2024-12-31Immunoglobulin variable domains
#97 | 2017-04-20STABILIZED SINGLE DOMAIN ANTIBODIES
#98 | 2017-04-06AMINO ACID SEQUENCES DIRECTED AGAINST RANK-L AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF BONE DISEASES AND DISORDERS
#99 | 2017-04-06SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
#100 | 2017-03-23 β Patent 11,009,511 granted on 2021-05-18Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
Also check out ABLYNX NV's (Zwijnaarde, Belgium) applicant profile with 94 patent applications submitted.
3818 β